![]() Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | SIGA Technologies SIGA Technologies is a biopharmaceutical company that develops treatments for infectious diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 2001 | Founding Date 1995 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Fremont, US HQ | Locations Kunming, CN HQ | Locations New York, US HQ Corvallis, US |
Employees | Employees 244% decrease | Employees 2,388 | Employees 4515% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.3 b | Valuation ($) 507.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) $94.6m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods $29.7m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit $64.9m (FY, 2025) |
Net income | Net income N/A | Net income ¥125.2m (FY, 2025) | Net income $23.3m (FY, 2025) |

Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View companySIGA Technologies is a biopharmaceutical company that develops treatments for infectious diseases.
View company